"no other company apart from Oventus has airways in the side of their devices or is adaptable for exvent which means the efficacy of the Optima falls between other MAD's and CPAP , so it is in a new market segment all of its own"
I'm just starting to look at this company and plough's comment sums up the potential appeal as I see it. I'd appreciate any thoughts on how well protected their IP is. What is the risk of other MAD suppliers being able to also sell devices with airways in the side?
- Forums
- ASX - By Stock
- OVN
- Ann: FDA Clearance for O2Vent Optima Oral Device
Ann: FDA Clearance for O2Vent Optima Oral Device, page-38
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
STX
Strike hands $48.5M contract to Clarke Energy to produce 20x 4.5MW gas engines for Sth Erregulla
TG1
TechGen Metals kicks off airborne geophys survey at Sally Downs copper play – a first for the permit
GML
Gateway Mining sells WA Eastern Montague gold project to Brightstar for $14M – half of that in shares